Aequus Pharmaceuticals Inc (TSX:AQS)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - AQS

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - AQS

  • Market CapCAD17.910m
  • SymbolTSX:AQS
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINCA0076361033

Company Profile

Aequus Pharmaceuticals Inc is a Canada based specialty pharmaceutical company. The firm's operating segments are Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. Aequus is developing a pipeline of products in neurology and psychiatry. The company's launched and pipeline products are Tacrolimus IR, Vistitan, AQS1304, AQS1303, and others.Aequus Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing differentiated products. It offers products like Topiramate XR, Oxcarbazepine XR, Tacrolimus Immediate Release, Vistitan, and other products.

Latest AQS news

Currently there for this company. Visit our news hub for other news .